Skip to content

Benefits of participating in art museum activities on health and wellbeing

Clinical evaluation of the benefits of engaging in arts on health and wellbeing of young adults participating in museum activities

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33089696
Enrollment
70
Registered
2025-10-30
Start date
2024-04-30
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Promoting wellbeing, quality of life and health Mental and Behavioural Disorders

Interventions

Randomisation by a computer-generated list to: Experimental: a museum visit, a semi-free visit to the FLR Museum exhibition halls Placebo comparator: a “neutral” experience in the FLR Museum non-exhib

Sponsors

Fondazione Luigi Rovati (FLR)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-30 years, all genders and self-identified as healthy 2. Fluent in Italian 3. Able to understand the study aim and to adhere to the study protocol procedures, and having signed an Informed Consent Form prior to the initiation of the study

Exclusion criteria

Exclusion criteria: Have already visited the FLR Museum venue

Design outcomes

Primary

MeasureTime frame
Change in the mean UCL Museum Wellbeing Measure, specifically the Positive Wellbeing Umbrella Generic, before and after the experience

Secondary

MeasureTime frame
1. Anxiety state evaluated by the STAI Y-1 before and after the experience 2. Neurophysiological parameters measured by EEG throughout the experience 3. Emotional activation measured by Galvanic Skin Response (GSR) throughout the experience 4. Blood pressure and heart rate measured before and after the experience by the OMRON EVOLV Automatic Upper Arm Blood Pressure Monitor 5. Heart rate variability (HRV) measured throughout the experience by the Shimmer3 GSR+ wrist device capturing an Optical Pulse/PPG (Photoplethysmogram) signal 6. Salivary levels of neuroendocrine stress hormones and biomarkers of catecholamines release measured before and after the experience. Saliva was collected using a SALIVETTE® device (SARSTEDT, Numbrecht, Netherlands) and analysed by commercially available kits.

Countries

Italy

Contacts

Public ContactLucio Rovati
lucio.rovati@fondazioneluigirovati.org+39 (0)399066104

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026